Medicare commission looks at tighter rules for physician-owned medical distributors

Special report: Homegrown fraud task forces promote collaboration
A Medicare commission is considering tightening up oversight of physician-owned medical distributors.

Worried that conflicts of interest could lead to fraud, the Medicare Payment Advisory Commission is considering recommending tighter rules to govern physician-owned companies that distribute medical products.

MedPAC members are looking to tighten oversight with tougher requirements in their recommendations to Congress, according to a report in The Hill. Some members argued the practice should be outlawed entirely because of the conflict that could result from doctors profiting on the devices they are recommending for surgical use on their patients.

RELATED: Detroit podiatrist charged in $13.9M Medicare fraud scheme

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

Physician-owned distributors (PODs) originally started as a way for physicians to cut costs by increasing their buying power and saving on devices. The PODs operate as middlemen, buying a device from manufacturers and selling them to a hospital at a higher price, the article said. Some hospitals have set up barriers to avoid anti-kickback problems with device distributors.

Critics say the PODs create incentives for their physician owners to perform more surgeries because they directly profit from the sale of more devices.

RELATED: MedPAC—Many hospitals charge too much for care

A Michigan surgeon, Aria Sabit, was sentenced to nearly 20 years in prison in January for $2.8 million in fraud, charged with performing unnecessary surgeries and overbilling for products, the report said. Two court cases related to Apex Medical Technologies, the POD he partially owned in California, are pending.

RELATED: ‘Life destroyed’—A doctor warns about accepting money from drug and device manufacturers

Suggested Articles

As drugmakers face billions in legal settlements and judgments, we must keep our eye on what will truly defeat the opioid crisis.

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.